Related Parties - Life Sciences Narrative (Details) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Aug. 04, 2025 |
Jan. 31, 2024 |
Jan. 30, 2024 |
|
| Related Party Transaction [Line Items] | |||||
| Share-based compensation expense | $ 2,700,000 | $ 3,400,000 | |||
| Accounts payable | 141,400,000 | 84,800,000 | |||
| Life Sciences | |||||
| Related Party Transaction [Line Items] | |||||
| Revenue | 12,500,000 | 9,800,000 | |||
| R2 Technologies | Related Party | Life Sciences | |||||
| Related Party Transaction [Line Items] | |||||
| Revenue | 3,600,000 | 1,400,000 | |||
| Related receivables from this subsidiary | 600,000 | 100,000 | |||
| Share-based compensation expense | 300,000 | 1,100,000 | |||
| Accounts payable | 200,000 | 0 | |||
| R2 Technologies | Lancer Promissory Note | Related Party | Life Sciences | |||||
| Related Party Transaction [Line Items] | |||||
| Short-term debt | $ 47,900,000 | $ 24,000,000.0 | |||
| Interest rate | 12.00% | 12.00% | |||
| R2 Technologies | Senior Notes, Due 2025, 20.00% | Related Party | Life Sciences | |||||
| Related Party Transaction [Line Items] | |||||
| Short-term debt | $ 17,400,000 | ||||
| Interest rate | 20.00% | 20.00% | 20.00% | ||
| X | ||||||||||
- Definition Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|